Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2

High dose (HD) IL-2 therapy has been used for almost two decades as an immunotherapy for metastatic melanoma. IL-2 promotes the proliferation and effector function of T and NK cells through the tyrosine phosphorylation and activation of signal transducer and activator of transcription factors (STAT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Geok Choo, Wu, Sheng, Jin, Lei, Hwu, Patrick, Radvanyi, Laszlo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094984/
https://www.ncbi.nlm.nih.gov/pubmed/27153543
http://dx.doi.org/10.18632/oncotarget.8683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094984/
https://www.ncbi.nlm.nih.gov/pubmed/27153543
http://dx.doi.org/10.18632/oncotarget.8683

Ejemplares similares